Trial · NCT04622709
Outcomes214
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 214
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 5 | Baseline and study week 5 (5 weeks after study medication start | Summarizing outcome events as a single arm (i.e., patients with a baseline 24-hour urine volume ≥200 mL and \< 200 mL as a single group) was pre-specified in the protocol. 36 participants completed the week 5 24-hour urine volume collection. Thus, the analysis population is 36 participants. | percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 12 | Baseline and study week 12 (12 weeks after study medication start) | Summarizing outcome events as a single arm (i.e., patients with a baseline 24-hour urine volume ≥200 mL and \< 200 mL as a single group) was pre-specified in the protocol. 33 participants completed the week 12 24-hour urine volume collection. Thus, the analysis population is 33 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 18 | Baseline and study week 18 (18 weeks after study medication start) | Summarizing outcome events as a single arm (i.e., patients with a baseline 24-hour urine volume ≥200 mL and \< 200 mL as a single group) was pre-specified in the protocol. Out of the 33 participants still enrolled in the study at week 18, 32 completed the week 18 24-hour urine volume collection. Thus, the analysis population is 32 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With A Serum Potassium <3.2 mEq/L at Week 1 | Study week 1 (1 week after study medication start) | 38 participants completed the week 1 blood collection. Thus, the analysis population is 38 participants. | percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 2 | Study week 2 (2 weeks after study medication start) | 37 participants completed the week 2 blood collection. Thus, the analysis population is 37 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 3 | Study week 3 (3 weeks after study medication start) | 37 participants completed the week 3 blood collection. Thus, the analysis population is 37 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 4 | Study week 4 (4 weeks after study medication start) | 37 participants completed the week 4 blood collection. Thus, the analysis population is 37 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 5 | Study week 5 (5 weeks after study medication start) | 36 participants completed the week 5 blood collection. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 6 | Study week 6 (6 weeks after study medication start) | 36 participants completed the week 6 blood collection. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 9 | Study week 9 (9 weeks after study medication start) | 36 participants completed the week 9 blood collection. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 13 | Study week 13 (13 weeks after study medication start) | 33 participants completed the week 13 blood collection. Thus, the analysis population is 33 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 17 | Study week 17 (17 weeks after study medication start) | 33 participants completed the week 17 blood collection. Thus, the analysis population is 33 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 1 | Study week 1 (1 week after study medication start) | 38 participants completed the week 1 blood collection. Thus, the analysis population is 38 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 2 | Study week 2 (2 weeks after study medication start) | 37 participants completed the week 2 blood collection. Thus, the analysis population is 37 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 3 | Study week 3 (3 weeks after study medication start) | 37 participants completed the week 3 blood collection. However, there was laboratory error and serum magnesium levels were only available for 36 participants. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 4 | Study week 4 (4 weeks after study medication start) | 37 participants completed the week 4 blood collection. However, there was laboratory error and serum magnesium levels were only available for 36 participants. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 5 | Study week 5 (5 weeks after study medication start) | 36 participants completed the week 5 blood collection. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 6 | Study week 6 (6 weeks after study medication start) | 36 participants completed the week 6 blood collection. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 9 | Study week 9 (9 weeks after study medication start) | 36 participants completed the week 9 blood collection. Thus, the analysis population is 36 participants. | Percentage of participants | NUMBER |
| PRIMARY | Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 13 | Study week 13 (13 weeks after study medication start) | 33 participants completed the week 13 blood collection. Thus, the analysis population is 33 participants. | Percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04622709/outcomes